BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22305583)

  • 1. Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication.
    Kim J; Park C; Ok T; So W; Jo M; Seo M; Kim Y; Sohn JH; Park Y; Ju MK; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Sommer P; No Z
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2119-24. PubMed ID: 22305583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.
    Kim J; Ok T; Park C; So W; Jo M; Kim Y; Seo M; Lee D; Jo S; Ko Y; Choi I; Park Y; Yoon J; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Liuzzi M; Sommer P; No Z
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2522-6. PubMed ID: 22374216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
    Long J; Zhang DH; Zhang GH; Rao ZK; Wang YH; Tam SC; He YP; Zheng YT
    Yao Xue Xue Bao; 2010 Feb; 45(2):228-34. PubMed ID: 21348416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors.
    Wang Z; Wang M; Yao X; Li Y; Qiao W; Geng Y; Liu Y; Wang Q
    Eur J Med Chem; 2012 Apr; 50():361-9. PubMed ID: 22369862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
    Yu M; Liu X; Li Z; Liu S; Pannecouque C; Clercq ED
    Bioorg Med Chem; 2009 Nov; 17(22):7749-54. PubMed ID: 19819705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(Alkyl/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studies.
    Rotili D; Samuele A; Tarantino D; Ragno R; Musmuca I; Ballante F; Botta G; Morera L; Pierini M; Cirilli R; Nawrozkij MB; Gonzalez E; Clotet B; Artico M; Esté JA; Maga G; Mai A
    J Med Chem; 2012 Apr; 55(7):3558-62. PubMed ID: 22428851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies on new DABOS: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity.
    Sbardella G; Mai A; Artico M; Chimenti P; Massa S; Loddo R; Marongiu ME; La Collat P; Pani A
    Antivir Chem Chemother; 2001 Jan; 12(1):37-50. PubMed ID: 11437321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
    Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2013 Jan; 23(1):153-7. PubMed ID: 23206860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
    Zhan P; Chen X; Li X; Li D; Tian Y; Chen W; Pannecouque C; De Clercq E; Liu X
    Eur J Med Chem; 2011 Oct; 46(10):5039-45. PubMed ID: 21872971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.
    Venkatachalam TK; Mao C; Uckun FM
    Bioorg Med Chem; 2004 Aug; 12(15):4275-84. PubMed ID: 15246104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2.
    Jiang T; Kuhen KL; Wolff K; Yin H; Bieza K; Caldwell J; Bursulaya B; Tuntland T; Zhang K; Karanewsky D; He Y
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2109-12. PubMed ID: 16464578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety.
    Seto M; Aikawa K; Miyamoto N; Aramaki Y; Kanzaki N; Takashima K; Kuze Y; Iizawa Y; Baba M; Shiraishi M
    J Med Chem; 2006 Mar; 49(6):2037-48. PubMed ID: 16539392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
    He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel synthetic route for the anti-HIV drug MC-1220 and its analogues.
    Loksha YM; Globisch D; Loddo R; Collu G; La Colla P; Pedersen EB
    ChemMedChem; 2010 Nov; 5(11):1847-9. PubMed ID: 20715285
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
    Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
    Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiester amidates of unsaturated nucleoside analogues: synthesis and anti-HIV activity.
    Winter H; Maeda Y; Uchida H; Mitsuya H; Zemlicka J
    J Med Chem; 1997 Jul; 40(14):2191-5. PubMed ID: 9216838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
    Elgemeie GE; Mansour OA; Metwally NH
    Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.